Ukraine Quarterly Beverage Tracker Fourth Quarter 2017-Ken Research

GlobalData's Ukraine Quarterly Beverage Tracker Q4-17 covering soft drinks, dairy drinks, hot drinks and alcoholic drinks is an essential tool for keeping up-to-date with the latest industry performance and developments on a quarterly basis, covering:

Top line consumption volumes for Q4-2017 vs Q4-2016, moving annual totals (MAT), full year 2016 provisional data and 2017 forecasts for all beverage categories.

Carbonates consumption data for Q4-2017 vs Q4-2016, moving annual totals (MAT), full year 2016 provisional data and 2017 forecasts split by regular vs low calorie and key flavor.

An economic mood indicator with an at a glance assessment of industry confidence levels, private label performance vs brands and price trends.

Insightful and valuable analysis of the drivers behind the latest quarterly trends and assumptions for full year 2017.

Flat rate of growth for all commercial beverages in Q4-17. Annual rate of decline stood at 1%, the softest negative growth seen in recent years.

The soft drinks market posted positive annual growth for the first time in several years but the alcoholic drinks market continued to decline.

Q4-17 saw another period of moderate expansion. Retail sales expanded but industrial output growth remained incredibly slow.

Gain an in-depth understanding of the most up-to-date trends in the Ukraine beverage industry to support and enhance your strategic planning.

Investigate the latest quarterly and emerging annual trends in Ukraine to back your marketing initiatives.

Analyze the latest beverage category 2017 forecast projections to make well-informed decisions on the outlook in the marketplace for your company.

View a selection of the key quarterly new soft drinks product launches and identify competitor activity.

Access a quarterly Special Focus on a current industry 'hot topic' offering qualitative insight from local consultants to determine opportunities for product innovation.

For More Information, Refer to the Link below:

https://www.kenresearch.com/food-beverage-and-tobacco/non-alcoholic-beverages/quarterly-beverage-tracker-fourth-quarter-2017-ukraine/149331-11.html

Related Reports:

https://www.kenresearch.com/food-beverage-and-tobacco/non-alcoholic-beverages/quarterly-beverage-tracker-fourth-quarter-2017-usa/149332-11.html

https://www.kenresearch.com/food-beverage-and-tobacco/non-alcoholic-beverages/quarterly-beverage-tracker-fourth-quarter-2017-united-kingdom/149330-11.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249

Drug Developments In Urinary Incontinence Market Outlook: Ken Research

Urinary incontinence is a symptom of general lifestyle habits resulting in the loss of bladder control which leads to involuntary urination. According to the study ‘URINARY INCONTINENCE  GLOBAL CLINICAL TRIALS REVIEW, H1, 2018’, the severity ranges from occasionally leaking urine on coughing or sneezing to having an urge to urinate that is so sudden and strong that you cannot get to a toilet in time. Though it occurs more often as people get older, urinary incontinence is not an inevitable consequence of aging. For affected people, simple lifestyle changes or medical treatment can ease discomfort or stop urinary incontinence.

Medications are available for people with bladder control issues. Anticholinergics are drugs that block the action of the chemical messenger acetylcholine in the central or peripheral nervous system responsible for sending signals to the brain that cause abnormal bladder contractions associated with overactive bladder. These drugs are widely used to tackle other ailments as well which include depression, Parkinson’s disease and epilepsy among others. It is well known that anticholinergics affect cognition and guidelines suggest they are to be avoided among frail elderly people. Over the past years prolonged exposure to anticholinergic drugs has been linked to long term cognitive decline including dementia. However, these studies have been limited in their ability to determine if the increased risk is specific to the anticholinergic action or not. However, recent studies by BMJ company reveal that anticholinergic drugs can significantly increase the susceptibility to dementia. CNN Health and PsychCentral studies also support these findings.

Mirabegron, marketed in the US as Myrbetriq, is a medication that relaxes the bladder muscles and can increase the amount of urine the bladder can hold. It may also increase the amount a person is able to urinate at one time, emptying the bladder more completely. This drug reacts with other medication and recent experimentation has led to some developments in this respect. In May 2018, Tokyo based Astellas Pharma Inc. announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the use of mirabegron in combination with the muscarinic antagonist, solifenacin succinate for the treatment of overactive bladder (OAB) with symptoms of urinary incontinence. Astellas Pharma Inc. is a Japanese company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products with urology being one of its focus sectors. The experts of their urology department believe that OAB patients may have symptoms that may not be fully managed by their current treatment but with the FDA approval of Myrbetriq in combination with solifenacin succinate, Astellas will be able to offer an additional treatment option to such people. These results have been based on data from the global Phase 3 SYNERGY 1, SYNERGY 2 and BESIDE studies. These studies had evaluated combination therapy with mirabegron and solifenacin succinate. These results are also proving safe as a controlled clinical safety study did not demonstrate increased urinary retention in Myrbetriq patients however, there have been other side effects noted.

Urinary incontinence treatment drugs have revealed new long term effects. Such effects are further being studied to give a deeper understanding to researchers. Since the most popular drugs are affecting the nervous system, their true potential is being carefully realized and approved, for safe use, by institutions such as FDA. Pharmaceutical companies such as Astellas which is combining internal capabilities with external expertise in the medical field appear at the forefront of healthcare change to turn innovative science into value for patients.     

To know more, click on the link below:     

https://www.kenresearch.com/healthcare/general-healthcare/urinary-incontinence-global-clinical/150992-91.html

Related Report:-

https://www.kenresearch.com/healthcare/pharmaceuticals/urinary-incontinence-pipeline/45989-91.html

https://www.kenresearch.com/healthcare/pharmaceuticals/global-inhalers-industry/102532-91.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

+91-9015378249

Sizing the Needle Free Injection Market Outlook: Ken Research

The needle technology that is referred to as hypodermic needle was first used by ancient Romans and Greeks to inject cures into the body and prevent death via snakebites or poisoned weapons. Christopher Wren was the first documented scientist who performed the first intravenous injections using hypodermic needles in the late 17th century. As technology advanced and pharmaceutical industry reached a breakthrough, newer technologies were incorporated within this segment. The recent technology used is the development of needless injections. Needle free Injection technology (NFIT) is a very new concept that is being used to delivery specific type of drugs through the skin using scientific principles of shockwaves, pressure, Lorentz or electrophoresis which forces the drug into the skin thereby negating the use of a needle in an injection.

According to the study, ‘Needle Free Injections - Medical Devices Pipeline Assessment, 2018’, some major companies and organizations developing this technology are  B. Braun Melsungen AG, Boston Scientific Corp, Crossject SA, Enable Injections Inc, Enesi Pharma Ltd, Eternity Healthcare Inc., Inovio Pharmaceuticals Inc, Medical International Technologies (Mit Canada) Inc, PharmaJet Inc, Queen's University, Takeda Pharmaceutical Co Ltd, Teva Pharmaceutical Industries Ltd

The basic principle behind NFIT is that a drug in a pre measured amount is loaded in cassettes which are then transmitted into the body via the skin by harnessing a strong amount of energy. The force can be generated either via electromagnetic devices or shockwaves or any other form of energy that is capable enough to impart motion to the medicine. There are various classifications for these needlefee devices. They are on the basis of working (Spring system, laser powered, energy propelled systems) or on the basis of type of load (liquid, powder or projective) or on the basis or site of delivery.

This technology can be used to administer local anesthesia, direct palmar BoNT-ONA and Intralesional corticosteroids to name a few. Recently clinical trials have revealed that intraject technology delivers reliable subcutaneous injections. Studies have also revealed that large and complex drugs are not modified when huge pressure is applied during the process of administration via needle free technology.

The prime advantage of this device is that it saves the patient from unnecessary pain and not only this but physical drug can also be administered via this technology. Although traditional hypodermic needles are cheap and quick to use however, the use of these needles often cause needle stick injury which leads to infections or injury to the skin which results in further expensive treatments. It is because of this reason many US states in 2015 came up with legislations requiring the use of needle free systems wherever it was available. A huge number of medicines are now being administered via injections rather than oral or any other mode.  Each year the medical experts are devising techniques to shift from oral medication to direct mode. This could also prove to be a key driver for the needle free injection market.

Market forces have led to pharmaceutical companies to adopt newer technology in their devices which propagates the needle free injection market. The future of this sector seems promising as consumer preferences clearly show that needle less technology is the future.

To know more, click on the link below:

https://www.kenresearch.com/healthcare/medical-devices/needle-free-injections/151036-91.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

0124-4230204

Changing Dynamics Of Global Inhaler Market Outlook: Ken Research

According to the study, ‘INHALERS - MEDICAL DEVICES PIPELINE ASSESSMENT, 2018’, some major companies or organizations that engage in device manufacturing and distribution or research are Boehringer Ingelheim GmbH, Pneuma Respiratory Inc, Sandoz International GmbH, University of Kansas, Virginia Commonwealth University

The first use of inhaler technology can be traced by to 4000 years when people smoked Atropa Belladonna as a cough remedy. The inhaler device technology has improved significantly especially during the period 2010-2015. The first latest technology of inhaler devices was developed in the mid 201th century when pressurized metered dose inhaler (MDI) was invented). These devices are most widely used to treat conditions like COPD and asthma however, these devices are also suitable for other therapeutic areas especially nasal drug administration.

Due to positive trends in the inhaler market, companies have the opportunity to cash in on the growing trend however they also face many issues like dynamic regulatory environment and generic competition. The entire inhaler market is divided into two segments namely metered dose inhaler (MDI) and dry powdered inhaler. The majority users prefer to use dry powdered devices which have translated into their greater share within the market.

Some trends that have changed the landscape of this market are:-

Environmental Concerns – Environmental concerns have become very prominent especially after the Montreal Protocol in 1989 which had a major impact on inhaler market as companies were required to phases of CFC emitting devices. Due to hazards looming over the world environment, companies introduced HFA propellants. This was the major reasons that lead to the development of the first dry powdered inhaler.

Device designs – Growing consumer importance has resulted in companies changing their device designs to enable efficient utilization of the drug. Even regulatory authorities such as FDA recommend patient friendly device designs.

Financial Constrains – All the companies do not possess the same financial and growth potential, therefore are forced to merge with some bigger firms. As a result of this, competition in this sector is increasing day by day which has forced companies to be faster and leaner.

One of the major factor leading to customer satisfaction in the inhalers market is customer feedback and intelligent. In light of this many companies are utilizing smart phone technology to tap into customer feedback and also using analysis tool to monitor the feedback to the best of their use. Not only this, the inhaler manufacturers have the ability to provide direct feedback methods along with their products. Earlier, companies used to outsource production to emerging markets in order to reduce overall costs however, in the present times the production has been shifted to developed countries such as USA or countries of Europe. This has been done due to availability of better technological infrastructure in advanced countries.

The global inhalers market is growing at a much faced paced trend and companies need to innovate in their technology and distribution mechanism in order to remain at the top of the recent developments. The growth potential for this industry is immense given that companies and institutions are able to tap into this potential and translate it into real numbers.

To know more, click on the link below:     

https://www.kenresearch.com/healthcare/medical-devices/inhalers/151039-91.html

Related Report:-

https://www.kenresearch.com/healthcare/pharmaceuticals/global-smart-inhalers-industry/102529-91.html

https://www.kenresearch.com/healthcare/pharmaceuticals/global-inhalers-industry/102532-91.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

+91-9015378249

Rising Biodegradable Stent Technology Market Outlook: Ken Research

As the global trend towards rising health concerns takes pace and increasing adult diseases coupled with environment pollution, a strong emphasis is placed on the importance of treatment and prevention via diagnosis. Due to this shift to rising research coupled with wellness, the demand for advanced medical devices is expected to increase at a fast pace. As the global population ages, identification and treatment of heart diseases has gained paramount importance. Various reports conducted by scientists reveal that major cause for natural deaths in human beings is related to heart one way or the other which translates into greater demand for heart treatment devices especially stents.

According to the study, ‘Coronary - Medical Devices Pipeline Assessment, 2018’, some major institutions and organizations developing this technology are Abbott Vascular Inc., AlviMedica Medical Technologies Inc., Amaranth Medical Inc, Boston Scientific Corp, Cardionovum GmbH, Cardiorev Pte Ltd, Medinol Ltd, Medlogics Device Corp, Medtronic plc, S3V Vascular, Technologies Vornia Biomaterials Ltd and Xenogenics Corporation. The top 3 companies that are Abbott, Boston Scientific, and Medtronic enjoy a huge share in the market place and thus make the entry of new players significantly difficult.

Stents are basically of two categories, vascular and non vascular stents. Vascular stens are further sub divided into coronary, peripheral, and neurovascular stents.  A coronary stent is a device which is tube shaped which is used to keep the arteries open for the treatment of coronary heart diseases. Peripheral arteries are balloon shaped device used to treat stenotic lesions in different arteries. These stents are not used to treat coronary, cervical or cerebral vessel. Neurovascular stents are used for treating severe carotid artery stenosis. These stents are particularly used for high surgical risk patients.

Many innovations have taken place in order to improve the efficiency of a particular stent. For instance latest requirement was to make stents more flexible and therefore they are covered with CoCr allow to improve their elasticity. Many stents suffered from stent restenosis. In order to prevent this condition, stents are being covered with an immunosuppressive agent; these stents have gained widespread popularity in Korea. The current technology being worked upon is stents that are dissolved in the heart after their application is completed. Although many stent manufacturers are developing this technology, the rate of acceptance and adoption in clinical trials is low. However, once this technology is developed it shall bring a paradigm shift in the global stent market. Due to various anti-proliferative drugs and the polymer coating of the drug, the options available with patients have expanded. Scientists have recently conducted clinical trials for biocompatible scaffolds. The current trends in advances in the stent technology are mainly driven by rising DES that are drug eluting stents.

There can be variations in the results of global stent market 5 years down the line, however many predict this industry is expected to grow at a rapid rate and an increased growth rate in the biodegradable stent market due the benefits of application it posses. Social cost associated with manufacturing this device can also rise in the future thus making it absolutely necessary to make these devices patient friendly especially for old age population.

To know more, click on the link below:

https://www.kenresearch.com/healthcare/medical-devices/coronary-stents/151005-91.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

0124-4230204

Theoretical And Equipment Advances In Peripheral Neuropathy Market Outlook: Ken Research

Peripheral neuropathy refers to the conditions that result when nerves that carry messages to/from the brain and spinal cord, from/to the rest of the body are damaged or diseased. There are several different kinds of peripheral neuropathies that range from nerve damage linked with diabetes to carpal tunnel syndrome which is a traumatic injury common after chronic repetitive use of the hands and wrists such as with computer use. According to the study ‘Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2018’ as a group peripheral neuropathies are common especially among people over the age of 55. Neuropathies are typically classified according to the problems they cause or what is at the root of the damage.

The diagnosis of peripheral neuropathy has many aspects apart from physical tests like blood test and neurological examination. CT or MRI scans can look for herniated disks or tumours. Electromyography records electrical activity in the muscles to detect nerve damage. Today many improvements are being made to the way tests are conducted and diseases are being diagnosed. Take for example the case of diabetic peripheral neuropathy, various tests check the sense perception in the feet but vary in type. Simple tests are those that can be conducted quickly and easily in primary care without laboratory equipment. There are some limitations to these simple tests, an example being the variable amplitude of the 128 Hz tuning fork. A new test, VibraTip, is appearing as a valuable alternative as it omits consistent amplitude and may offer improved diagnostic accuracy.

McCallan Medical Ltd. Is a US based company that manufactures medical and dental equipments. It has been acquired by UK based Bionical Group. Both companies expect to mutually benefit from this acquisition as it will not only increase Bionical’s global reach, support and expertise but McCallan’s established US base and distribution channels which will also enhance and advance Bionical’s foothold in the US.

McCallan Medical, UK has developed the VibraTip which has been specifically designed to overcome the limitations of tuning fork for testing the integrity of vibration sense in clinic and even by the bedside. It provides a vibratory stimulus for the purpose of detecting diabetic peripheral neuropathy in patients with type 1 or 2 diabetes. It has sufficient battery life for several months of routine use and can easily be wiped or cleaned. It is small enough to be concealed in the hand while its silent switch and quiet operations minimize cueing. Even its head has been carefully designed as it is rounded which allows vibration sense to be assessed specifically and rapidly from almost any angle.

Apart from this, researchers are also testing a new non-addictive treatment inspired from a surprising source. This development comes in response to several cases in which doctors were not able to identify the cause of peripheral neuropathy. Currently a new drug is being tested that will tackle neuropathic pain and is inspired from the toxin found in Japanese pufferfish as the drug copies how the fish toxins disrupt signals to the body. As of now it is only known as CC8464. The drug is expected to target only peripheral nerve fibers and not the brain. Researchers say that since the drug bypasses the brain and affects only the peripheral nerves it may not be addictive. The potential new drug is being developed by the New Jersey based company Chromocell. The US FDA has granted the drug ‘fast-track’ status and it is in phase one clinical trials.

Peripheral neuropathic research has led to developments in equipment as well as knowledge base. New devices and drugs are being researched and examined by globally recognized agencies which ensure reliability. Medical developments in this respect are also bringing businesses together with US and UK companies leading the way.

For More Information, Refer to the Link below:

https://www.kenresearch.com/healthcare/general-healthcare/peripheral-neuropathy-global-clinical/150993-91.html

Related Reports:

https://www.kenresearch.com/healthcare/pharmaceuticals/peripheral-neuropathy-sensory-neuropathy-review/47222-91.html

https://www.kenresearch.com/healthcare/pharmaceuticals/diabetic-peripheral-neuropathy/135695-91.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249

Developing Economies in Asia to Boost Copper Foil Tape Industry: Ken Research

Copper foil tape is a thin strip of copper backed with adhesive and is found at hardware, gardening stores and electronic stores. Copper foil tape is used in gardens to keep slugs and snails away from gardens, potted plants, trunks of fruit trees, and other shrubs. It is also used as electromagnetic shielding, low-profile surface mount transmission line in electronics and production of tiffany lamps. Copper foil tape is a popular choice across all industrial applications. Copper foil tape meets the exact needs of applications in industries such as EMI/RFI Shielding, arts, crafts, labels, stained glass, transformers, batteries, motors and others. Adhesive copper foil tape is produced in gauges, at varying thicknesses, as conductive adhesives and non-conductive adhesives. Copper foil tape with non-conductive adhesives is the most commonly available product.

According to the study “Asia Copper Foil Tape Industry Situation and Prospects Research report”, it was observed that there is a robust growth in copper foil tape market because of it use in  various industries such as automotive, transportation, electronics, consumer goods, consumer appliances, defence and aerospace which is fuelling the cooper foil tape market in Asia. It is widely used in many industries because it possesses properties such as resistance to flame, moisture, weather, dirt, and UV degradation. Copper foil tapes are manufactured with pressure-sensitive adhesives like silicone, acrylic, rubber, ethylene-vinyl acetate (EVA), and acryl ate to provide a vapour barrier and superior sealing. Copper foil tapes are extensively used in heating, ventilation, and air conditioning (HVAC) systems. Acrylic adhesives are used in countries with cold weather conditions which permit the tapes to adhere very well in high humidity and low-temperature conditions. They tapes create air-tight seals in ventilation systems and duct work producing a flexible bond and providing extreme temperature resistance.

Copper foil tapes are extensively used in the electronics industry for shielding electromagnetic wave and making contact for transformers. Copper foil tapes offers superior performance in various temperature conditions. Acrylic-based copper foil tapes are more versatile and better resistant to chemicals, solvents and water. Automotive and transportation industry, use copper foil tapes for sound dampening, heat sealing, and auto repair needs. Asia copper foil tape market is categorized based on function type such as conductive tapes and adhesive tapes. Based on product types copper foil tapes are classified into tape copper foil and sheet copper foil. These tapes are used majorly in electronics industry, cable wrapping and others. Asia’s copper foil tape market is spread across China, India, Japan, Korea, Saudi Arabia and other regions. The leading players in Asia’s copper foil tape market are 3M, Ampetronic, Teraoka Tape, PPI Adhesive Products, Chibitronics, Jans Copper, SIKA and VIACOR Polymer GmbH.

Asia accounts for a largest share in copper foil tape market with China being the major consumer. Additionally, Indian electronics industry is a part of the fastest growing economies in Asia with increasing demand from smart phones and electronics industry. The demand for circuit boards and batteries is anticipated to drive the demand for copper foil tape in these regions. Rapid urbanization, government spending, investment and increase consumers’ spending are a few factors driving the infrastructure development in Asia’s construction industry coupled with copper foil tape industry. Cooper foil tapes are used in various equipments used for building heating, ventilation and air conditioning. The rising demand for copper foil tapes is anticipated to drive the market at a faster pace due to rising need for environmental protection of assemblies and surfaces from extreme chemical and temperature conditions in the next few years.

To know more, click on the link below:

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/asia-copper-foil-tape-industry-situation-and-prospects-research-report/145757-101.html

Related Reports by Ken Research

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/asia-copper-foil-tape-industry-situation-and-prospects-research-report/145757-101.html

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/asia-copper-cathode-industry-situation-and-prospects-research-report/145756-101.html

Contact Us:

Ken Research 

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

+91-9015378249

Canadian Solar Inc Market Research Report: Ken Research

Canadian Solar Inc Market Research Report provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The Report Includes:-

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Canadian Solar Inc (Canadian Solar) is a solar power company. It designs, develops, and manufactures solar ingots, wafers, modules, cells, and other solar power products. The company's products include a range of solar modules for use in residential, commercial and industrial solar power generation systems; and specialty solar products include customized solar modules that customers incorporate into their own products and complete specialty products, such as portable solar home systems. Canadian Solar serves distributors, project developers, system integrators, and installers and EPC companies across Asia, America, Europe, and other regions. It has manufacturing facilities across the world. Canadian Solar is headquartered in Guelph, Ontario, Canada. The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

To know more, click on the link below:                                                                      

https://www.kenresearch.com/energy-and-utilities/power/canadian-solar-inc-financial-strategic/21950-103.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

+91-9015378249

Rising Demand of Renewable Energy in New Zealand Power Market Outlook: Ken Research

Energy is an essential ingredient for the economic and social prosperity of any country. Energy consumption highlights the economic prosperity or the healthy functioning of any country. The energy markets and policy frameworks have witnessed immense changes in New Zealand in the past decade. New Zealand energy market is a perfect example of an effective ecosystem. New Zealand has ample amount of energy resources to meet its need and notably, it is bestowed with many renewable energy resources. New Zealand has one the highest production capability of geothermal energy and has huge hydro power potential. In recent years market has been able to ensure supply stability thereby ensuring that no unexpected price hikes take place. The leading players in energy segment are Meridian Energy Ltd, Genesis Energy Ltd, Contact Energy Ltd, Mercury NZ Ltd, Infratil Ltd

According to the study, ‘New Zealand Power Market Outlook to 2030, Update 2018 - Market Trends, Regulations, and Competitive Landscape’, Although New Zealand has both ample renewable and non renewable resources, it imports some of its energy requirements from other country in order to meets in domestic demand. The country actively exports fossil fuels which improves the overall revenue of the government. However due to the requirement of importing, New Zealand is rendered dependent on factors and forces that are outside its control.

Coal Production has witnessed a falling trend since the past 5 years at in 2016; it was reported to be at an all time low. The total coal production in the country fell as compared to last year because of fall in production destined in Northern Islands and international markets. The falling coal production in the northern region can be attributed to lower demand for electricity generate via coal. The production in the western region is primarily used for export purposes however due to falling international coal prices; the production in this region also saw a decline. The coal generation in other parts of the country rose but was not high enough to lift the overall market volume.

New Zealand’s oil and gas production dates back to the 1950s. The modern industry in New Zealand is built on new age technological infrastructure and competitive global oil and gas regime. New Zealand saw a huge production in its oil and gas in the late 20th century and between 2005 -2020, however this rising trend saw a downturn post 2010. In 2016, the oil production fell which can be attributed to 2 month shutdown of Maari field after a crack was discovered in well head platform. Oil exports also fell however; Imports witnessed a rise due to increased demand for diesel. The domestic transportation industry is the largest consumer of oil and gas.

Renewable energy sources in New Zealand include hydro, wind, geothermal, solar, woody biomass, biomass and liquid bio fuel. Overall rising trend was recorded in renewable energy production. High electricity production in 2016 from hydro was a key driver for causing this increase. In the recent years, a substantial portion of electricity generation is by renewable energy resources. Wood biomass has also emerged with a huge share in overall energy production via renewable sources.

Due to favorable climatic conditions, the over demand and supply of electricity fell slightly in 2016. The Electricity market is regulated by the Electricity Industry Participation code which is administered by Electric Authority. Electric Authority was set up in 2010 to replace Electricity Commission.

The trends reveal that New Zealand is one of the few countries that are actually shifting towards renewable energy resources due to various environmental hazards associated with non renewable sources. The future for renewable energy can be characterized by high growth rate whereas uncertainty still looms over sources that are nonrenewable in nature.

To know more, click on the link below:

https://www.kenresearch.com/energy-and-utilities/power/new-zealand-power-regulations-competitive/151208-103.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

0124-4230204